Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305743 · ClinicalTrials.gov registry record · Phase 4
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
A Phase 4 study of Urinary Bladder, Overactive and Nocturia, sponsored by University of South Florida.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT04305743 is a Phase 4 study of Urinary Bladder, Overactive and Nocturia that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 60 participants, below the 358-participant average among 9 other Urinary Bladder, Overactive trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04305743, a Phase 4 study of Urinary Bladder, Overactive and Nocturia, is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for the treatment of overactive bladder or urgency urinary incontinence refractory to medical treatment.
Conditions Studied
Interventions
- DRUG OnabotulinumtoxinA 100 UNT
Study Locations (2)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- University of South Florida Health South Tampa Center for Advanced Healthcare - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-10-09 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04305743
The ClinicalTrials.gov registry entry for NCT04305743 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 9 other Urinary Bladder, Overactive trials with a reported enrollment target (83% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Urinary Bladder, Overactive appearing as the primary indexed condition, and to 1 intervention - of which OnabotulinumtoxinA 100 UNT is the first listed.
NCT04305743 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Florida.
Frequently Asked Questions
What is clinical trial NCT04305743 about?
NCT04305743 is a clinical study titled "Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A". Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of...
What is the current status of trial NCT04305743?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2019-10-09. Estimated completion is 2021-06-01.
What conditions does trial NCT04305743 study?
This clinical trial studies the following conditions: Urinary Bladder, Overactive, Nocturia, Urinary Urge Incontinence, Incontinence, Urinary, Incontinence, Urge.
What interventions are being tested in trial NCT04305743?
The interventions under investigation include: OnabotulinumtoxinA 100 UNT (DRUG).
Who is sponsoring clinical trial NCT04305743?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305743 being conducted?
This trial has 2 study locations across District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Bladder, Overactive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms
COMPLETED · Phase 4
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
ACTIVE NOT RECRUITING · Early Phase 1
-
INTIBIA Pivotal Study
ACTIVE NOT RECRUITING · NA
-
Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.